Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
| Sales | 555 | 1,737 | 738 | 1,630 | 2,112 |
| Cost of Goods | 810 | 0 | 0 | 937 | 434 |
| Gross Profit | 384 | 4,634 | 1,594 | 693 | 1,941 |
| Operating Expenses | 2,099 | 2,198 | 2,381 | 6,073 | 6,264 |
| Operating Income | -1,544 | -461 | -1,643 | -4,443 | -4,152 |
| Interest Expense | 10 | 32 | 11 | 395 | 333 |
| Other Income | 463 | 3,790 | 1,385 | 812 | 1,058 |
| Pre-tax Income | -1,091 | 3,298 | -269 | -4,025 | -3,427 |
| Income Tax | 44 | 520 | 76 | 93 | -199 |
| Net Income Continuous | -784 | 2,851 | -291 | -4,118 | -2,595 |
| Net Income Discontinuous | -1,330 | -2,273 | -4,150 | -805 | -941 |
| Net Income | $-2,115 | $505 | $-4,495 | $-4,923 | $-4,168 |
| EPS Basic Total Ops | -0.45 | 0.11 | -0.99 | -1.20 | -1.11 |
| EPS Basic Continuous Ops | -0.16 | 0.61 | -0.06 | -0.91 | -0.62 |
| EPS Basic Discontinuous Ops | -0.28 | -0.49 | -0.91 | -0.18 | -0.23 |
| EPS Diluted Total Ops | -0.44 | 0.11 | -0.99 | -1.09 | -1.11 |
| EPS Diluted Continuous Ops | -0.16 | 0.61 | -0.06 | -0.91 | -0.69 |
| EPS Diluted Discontinuous Ops | -0.28 | -0.49 | -0.91 | -0.18 | -0.25 |
| EBITDA(a) | $-1,466 | $146 | $-1,038 | $-4,443 | $-4,152 |